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Introduction {#s01}
============

Borderline personality disorder is a severe and complex psychological disorder characterized by long-term patterns of intense emotions, impulsive and self-destructive behaviors, and chaotic relationships. Borderline personality disorder is also associated with high rates of comorbidity. Individuals with borderline personality disorder meet criteria for an average of 3.0 to 3.4 current Axis I disorders (e.g. mood, anxiety, eating, psychotic, and substance use disorders) and 4.2 to 4.8 lifetime Axis I disorders \[[@bib-001],[@bib-002]\]. Although emphasis is often placed on the comorbidity between borderline personality disorder and mood disorders, anxiety disorders are equally and highly prevalent, with approximately 75-90% of individuals with borderline personality disorder meeting criteria for at least one lifetime anxiety disorder \[[@bib-003]-[@bib-005]\]. Despite the negative prognostic significance of anxiety disorders on borderline personality disorder \[[@bib-006]\], there is a paucity of research examining effective treatments for these frequently co-occurring disorders, particularly among severe borderline personality disorder patients. The present review will describe the existing research in this area and make suggestions for future directions.

The prevalence, course, and impact of anxiety disorders in borderline personality disorder {#s02}
==========================================================================================

Although the high rate of comorbidity between borderline personality disorder and PTSD has received the most theoretical and empirical attention, each of the anxiety disorders has been found to be prevalent among individuals with borderline personality disorder. Among borderline personality disorder inpatients, 88% meet criteria for a lifetime anxiety disorder, including PTSD (56%), panic disorder (48%), social anxiety disorder (46%), specific phobia (32%), obsessive compulsive disorder (16%), generalized anxiety disorder (14%), and agoraphobia (12%) \[[@bib-004]\]. Similarly, high rates of current and lifetime anxiety disorders have been found among borderline personality disorder outpatients \[[@bib-001]\], treatment-seeking individuals with borderline personality disorder \[[@bib-007]\], and community samples of borderline personality disorder individuals \[[@bib-005]\]. Anxiety disorders are more prevalent among borderline personality disorder patients than other clinical populations \[[@bib-001],[@bib-004]\], and among women than men with borderline personality disorder \[[@bib-005],[@bib-008]\]. Anxiety disorders also have a complex and variable course in borderline personality disorder, with high rates of remission (77-100%), recurrence (30-65%), and new onsets (15-45%) over 10 years of prospective follow-up \[[@bib-009],[@bib-010]\]. Perhaps most critically, anxiety disorders are associated with a heightened risk of suicidal and non-suicidal self-injury among individuals with borderline personality disorder \[[@bib-011]-[@bib-018]\] and have been found to decrease the likelihood of achieving remission from borderline personality disorder over time \[[@bib-006]\].

The efficacy of borderline personality disorder treatments for co-occurring anxiety disorders {#s03}
=============================================================================================

To date, there have been 14 randomized controlled trials (RCTs) that have examined the effects of borderline personality disorder treatments on anxiety, with all but one of these focused on general anxiety severity as opposed to specific anxiety disorder diagnoses ([Table 1](#tbl-001){ref-type="table"}). The one study that has evaluated the effects of borderline personality disorder treatment on anxiety disorder diagnoses found that, among suicidal borderline personality disorder women in Dialectical Behavior Therapy, rates of remission from anxiety disorders ranged from 35-47% \[[@bib-002]\]. These remission rates did not differ from those found in the Community Treatment by Experts control condition (24-54%), and were lower than those found for mood, substance, and eating disorders in Dialectical Behavior Therapy (64-88%) \[[@bib-002]\]. The remaining 13 studies have examined general anxiety severity and have found mixed results. At post-treatment and/or follow-up, nine studies found significant decreases in anxiety \[[@bib-019]-[@bib-028]\], one study did not find a significant decrease \[[@bib-029]\], and three studies did not report pre-post changes \[[@bib-030]-[@bib-033]\]. Additionally, six studies found significant treatment differences in anxiety outcomes \[[@bib-019]-[@bib-022],[@bib-026],[@bib-027],[@bib-033]\], whereas seven studies found no differences between treatments \[[@bib-023]-[@bib-025],[@bib-028]-[@bib-032]\]. Although these studies generally indicate that treatment for borderline personality disorder is associated with a significant reduction in anxiety severity, it is unknown if or how these improvements are related to anxiety disorder diagnostic status. Of note, several borderline personality disorder treatments that have been examined in RCTs have not yet been evaluated in terms of their impact on anxiety outcomes, including Schema-Focused Therapy, Systems Training for Emotional Predictability and Problem Solving, Dynamic Deconstructive Psychotherapy, and General Psychiatric Management (see \[[@bib-034]\] for a review of these treatments).

###### Anxiety-related outcomes in randomized controlled trials of treatments for borderline personality disorder

![](medrep-05-15-t001)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                Sample            N     Setting             Study length     Treatments                       Anxiety measure      Anxiety-related outcomes
  ------------------------------------ ----------------- ----- ------------------- ---------------- -------------------------------- -------------------- -------------------------------------------------------------------------------------
  Bateman et al.\                      Mixed gender\     38    Partial hospital\   Tx: 1.5 years\   Mentalization based\             Spielberger\         During treatment, state and trait anxiety significantly decreased in mentalization\
  (1999; 2001)\                        with BPD                and outpatient      Fu: 1.5 years    treatment; Treatment\            State-Trait\         based treatment but not in treatment as usual. During follow-up, state anxiety\
  \[[@bib-019],[@bib-020]\]                                                                         as usual                         Anxiety\             was significantly lower in mentalization based treatment than in treatment as\
                                                                                                                                     Inventory            usual.

  Bellino et al.\                      Mixed gender\     32    Outpatient          Tx: 6 months     Interpersonal\                   Hamilton\            Both treatments had a significant reduction in anxiety. There was no significant\
  (2006) \[[@bib-023]\]                with BPD\                                                    psychotherapy + fluoxetine;\     Anxiety Rating\      difference between treatments.
                                       and major\                                                   Clinical management +\           Scale                
                                       depression                                                   fluoxetine                                            

  Bellino et al.\                      Mixed gender\     26    Outpatient          Tx: 6 months     Cognitive therapy;\              Hamilton\            Both treatments had a significant reduction in anxiety. Cognitive therapy had a\
  (2007) \[[@bib-022]\]                with BPD\                                                    Interpersonal\                   Anxiety Rating\      significantly greater reduction in anxiety than interpersonal psychotherapy.
                                       and major\                                                   psychotherapy                    Scale                
                                       depression                                                                                                         

  Bellino et al.\                      Mixed gender\     44    Outpatient          Tx: 8 months     Interpersonal\                   Hamilton\            Both treatments had a significant reduction in anxiety. Interpersonal\
  (2010) \[[@bib-021]\]                with BPD                                                     psychotherapy adapted to\        Anxiety Rating\      psychotherapy + fluoxetine had a significantly greater reduction in anxiety than\
                                                                                                    BPD + fluoxetine; Clinical\      Scale                fluoxetine only.
                                                                                                    management + fluoxetine                               

  Clarkin et al.\                      Mixed gender\     90    Outpatient          Tx: 1 year       Transference focused\            Brief Symptom\       All three treatments had a significant reduction in anxiety. There was no\
  (2007) \[[@bib-024]\]                with BPD                                                     psychotherapy; Dialectical\      Inventory            significant difference between treatments.
                                                                                                    behavior therapy;\                                    
                                                                                                    Supportive therapy                                    

  Cottraux et al.\                     Mixed gender\     65    Outpatient          Tx: 1 year\      Cognitive therapy; Rogerian\     Beck Anxiety\        There was no significant difference between treatments for change in anxiety\
  (2009) \[[@bib-033]\]                with BPD                                    Fu: 1 year       supportive therapy               Inventory            from baseline. However, at the 1-year follow-up, anxiety was significantly lower\
                                                                                                                                                          in cognitive therapy than Rogerian therapy.

  Davidson\                            Mixed gender\     106   Outpatient          Tx: 1 year\      Cognitive behavioral\            Spielberger\         At post-treatment, there was no significant difference on state or trait anxiety\
  et al. (2006;\                       with BPD                                    Fu: 1 year\      therapy plus treatment as\       State-Trait\         between treatments. At the 1-year follow-up, cognitive behavioral therapy plus\
  2010) \[[@bib-030],[@bib-031]\]                                                  and 6 years      usual; Treatment as usual        Anxiety\             treatment as usual had significantly lower state anxiety than treatment as usual.\
                                                                                                                                     Inventory            At the 6 year follow-up, there was no significant difference between treatments.

  Doering et al.\                      Women with BPD    104   Outpatient          Tx: 1 year       Transference-focused\            Spielberger\         Both treatments had a significant reduction in anxiety. There was no significant\
  (2010) \[[@bib-025]\]                                                                             therapy; Community\              State-Trait\         difference between treatments.
                                                                                                    treatment by experts             Anxiety\             
                                                                                                                                     Inventory            

  Gratz et al.\                        Self-harming\     22    Outpatient          Tx: 3.5 months   Emotion regulation\              Depression\          There was a significant reduction in anxiety in emotion regulation group +\
  (2006) \[[@bib-026]\]                women with\                                                  group + treatment as\            Anxiety Stress\      treatment as usual, but not treatment as usual.
                                       BPD                                                          usual; Treatment as usual        Scales               

  Harned et al.\                       Women with\       101   Outpatient          Tx: 1 year\      Dialectical behavior\            Longitudinal\        No significant difference between treatments for rates of remission from\
  (2008) \[[@bib-002]\]                BPD and recent\                             Fu: 1 year       therapy; Community\              Interval\            anxiety disorders.
                                       and repeated\                                                treatment by experts             Follow-Up\           
                                       intentional\                                                                                  Evaluation           
                                       self-injury                                                                                                        

  Koons et al.\                        Women\            20    Outpatient          Tx: 6 months     Dialectical behavior\            Hamilton\            Neither treatment had a significant change in anxiety.
  (2001) \[[@bib-029]\]                veterans\                                                    therapy; Treatment as\           Anxiety Rating\      
                                       with BPD                                                     usual                            Scale                

  Linehan et al.\                      Women with\       39    Outpatient          Tx: 1 year\      Dialectical behavior\            Social Adjustment\   There was no difference between treatments in anxious rumination at 6 and\
  (1993) \[[@bib-032]\]                BPD                                         Fu: 1 year       therapy; Treatment as\           Scale --\            12 month follow-up.
                                                                                                    usual                            Self-Report          

  Soler et al. (2009) \[[@bib-027]\]   Mixed gender\     60    Outpatient          Tx: 3 months     Dialectical behavior\            Hamilton\            There was a reduction in anxiety in dialectical behavior therapy-skills training\
                                       with BPD                                                     therapy-skills training only;\   Anxiety Rating\      only but not standard group therapy.
                                                                                                    Standard group therapy           Scale                

  Turner et al.\                       Mixed gender\     24    Outpatient          Tx: 1 year       DBT-oriented therapy;\           Beck Anxiety\        Both treatments had a significant reduction in anxiety. There was no significant\
  (2000) \[[@bib-028]\]                with BPD                                                     Client-centered therapy          Inventory            difference between treatments.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BPD, Borderline personality disorder

The efficacy of anxiety disorder treatments for individuals with borderline personality disorder {#s04}
================================================================================================

Although numerous evidence-based treatments for anxiety disorders are available, borderline personality disorder patients, particularly those with a severe level of disorder, are likely to be excluded from these treatments due to suicidality, self-injurious behavior, and other co-occurring problems that are deemed primary or in need of immediate treatment \[[@bib-035],[@bib-036]\]. As a result, few studies have evaluated the efficacy of anxiety disorder treatments among individuals with borderline personality disorder, and the available research is limited to PTSD treatment studies. Results from three RCTs of cognitive-behavioral treatments for PTSD indicate that patients with borderline personality disorder or borderline personality characteristics exhibited a comparable rate of improvement as patients without borderline personality disorder or borderline personality characteristics \[[@bib-037]-[@bib-039]\]. However, borderline personality disorder patients (11%) were less likely than those without borderline personality disorder (51%) to achieve good end-state functioning \[[@bib-037]\]. Importantly, each of these studies excluded patients with acute suicidality as well as one or more other problems common in severe borderline personality disorder (e.g. substance use disorder, recent self-injury). Although some research has evaluated the impact of personality disorders on treatment outcome for non-PTSD anxiety disorders \[[@bib-040],[@bib-041]\], no studies have specifically evaluated the effect of borderline personality disorder. Thus, research on the use of anxiety disorder treatments among individuals with borderline personality disorder is limited by the small number of studies available, the exclusion of severe borderline personality disorder patients, and the lack of studies on anxiety disorders other than PTSD.

Recent advances in psychosocial treatments for borderline personality disorder and co-occurring anxiety disorders {#s05}
=================================================================================================================

Given the paucity of empirical data on the treatment of co-occurring borderline personality disorder and anxiety disorders, recent research has begun to emerge focused on developing and evaluating treatments for this population. To date, this research has focused exclusively on individuals with comorbid borderline personality disorder and PTSD. Harned and colleagues have developed a one-year outpatient treatment for suicidal and self-injuring individuals with borderline personality disorder and PTSD that integrates Dialectical Behavior Therapy with a modified version of Prolonged Exposure therapy for PTSD \[[@bib-042],[@bib-043]\]. To date, this treatment has been evaluated in an open trial (n = 13) with results indicating that it is feasible and safe to administer, and is associated with large and significant improvements in PTSD (pre-post *d* = 1.4 − 1.7; remission rate = 60-72%), intentional self-injury, and a number of secondary outcomes \[[@bib-044]\]. Pabst and colleagues \[[@bib-045]\] conducted a feasibility trial of Narrative Exposure Therapy for women with borderline personality disorder and PTSD (n = 10). Treatment primarily occurred in an inpatient unit, lasted an average of 14 sessions, and excluded patients who were unwilling to consent to a no-suicide contract, had attempted suicide in the past eight weeks, or had other severe comorbidities. The treatment was associated with significant reductions in PTSD (*g* = 0.92) and several secondary outcomes. Finally, although not intended specifically for borderline personality disorder patients, Bohus and colleagues have developed a 12-week residential treatment for women with childhood sexual abuse-related PTSD plus a current diagnosis of major depression, eating disorder, substance use disorder, and/or at least four borderline personality disorder criteria. Individuals with a suicide attempt in the past four months are excluded. This treatment combines modified Dialectical Behavior Therapy and trauma-focused cognitive-behavioral approaches \[[@bib-046]\] and has been evaluated in an open trial (n = 29) \[[@bib-047]\] and an RCT (n = 74) \[[@bib-048]\], in which borderline personality disorder patients constituted 24-42% of the samples. Both studies have shown large and significant reductions in PTSD (*d* = 1.2 − 1.5; remission rate = 35-36%) and a number of secondary outcomes \[[@bib-047],[@bib-048]\] with one study finding that results were comparable between patients with and without borderline personality disorder \[[@bib-048]\]. Although these treatments have shown promising results, more research is needed to replicate these findings using randomized controlled designs with larger samples of borderline personality disorder patients.

Future directions {#s06}
=================

Given the high rate of co-occurring anxiety disorders among borderline personality disorder patients, as well as the negative impact of these disorders on achieving remission from borderline personality disorder, it is imperative that additional research continues to evaluate how to effectively treat anxiety disorders among individuals with borderline personality disorder. To date, the available research has focused exclusively on evaluating treatments for PTSD among borderline personality disorder patients, and no research has yet evaluated treatments for other types of anxiety disorders in borderline personality disorder. In addition, with the exception of Dialectical Behavior Therapy, the impact of existing borderline personality disorder treatments on specific anxiety disorders has not been examined.

As efforts to develop and evaluate treatments for co-occurring borderline personality disorder and anxiety disorders continue, attention should be paid to tailoring these treatments to borderline personality disorder patients with various levels of disorder. For example, it may be the case that existing, brief (9-12 week) anxiety disorder treatments can be implemented safely and effectively among borderline personality disorder patients with a mild level of disorder (e.g. those without suicidal and self-injurious behaviors or severe comorbidities) \[[@bib-037],[@bib-038]\]. Borderline personality disorder patients with a moderate level of disorder (e.g. low risk non-suicidal self-injury without serious suicidality, significant but non-disabling deficits in interpersonal and emotion regulation skills) may benefit from longer (12-16 week) and/or more intensive (e.g. residential) sequential treatments that implement strategies from borderline personality disorder treatments (e.g. skills training) prior to targeting anxiety disorders \[[@bib-047]-[@bib-049]\]. Finally, longer-term treatment (e.g. one year) that provides integrated treatment for borderline personality disorder and anxiety disorders may be necessary for borderline personality disorder patients with a severe level of disorder (e.g. recent serious suicidal and/or self-injurious behaviors, severe comorbidities, disabling psychosocial impairment) \[[@bib-044]\].

Within this general research agenda, several important questions remain to be addressed. First, it will be important to develop empirically-derived criteria for determining when to target anxiety disorders among individuals with borderline personality disorder, particularly in the context of multiple other severe problems. For example, it is not yet clear whether anxiety disorders can be safely and effectively treated among borderline personality disorder patients who are actively engaging in non-suicidal self-injury. It is also possible that these readiness criteria may differ depending on the treatment setting (e.g. inpatient/residential versus outpatient), type of anxiety disorder (e.g. PTSD versus other diagnoses), and/or the relationship of anxiety disorder symptoms to suicidal and self-injurious behaviors. Finally, some research has begun to identify common factors underlying borderline personality disorder and anxiety disorders, including a tendency to experience negative emotions combined with efforts to try to alter or avoid these emotions \[[@bib-050]-[@bib-053]\]. The extant research suggests that borderline personality disorder treatments that address these common factors may be sufficient to facilitate improvements in general anxiety severity. However, additional research is needed to determine whether more targeted anxiety disorder treatment is necessary to achieve full remission from these disorders during treatment for borderline personality disorder.
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